Repro Cash Ratio vs End Period Cash Flow Analysis

KRMD Stock

USD 3.66 0.14 3.98%

Repro Med financial indicator trend analysis is much more than just breaking down Repro Med Systems prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Repro Med Systems is a good investment. Please check the relationship between Repro Med Cash Ratio and its End Period Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Cash Ratio vs End Period Cash Flow

Cash Ratio vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Repro Med Systems Cash Ratio account and End Period Cash Flow. At this time, the significance of the direction appears to have strong relationship.

The correlation between Repro Med's Cash Ratio and End Period Cash Flow is 0.67. Overlapping area represents the amount of variation of Cash Ratio that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Repro Med Systems, assuming nothing else is changed. The correlation between historical values of Repro Med's Cash Ratio and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Ratio of Repro Med Systems are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Cash Ratio i.e., Repro Med's Cash Ratio and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.67

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cash Ratio

End Period Cash Flow

Most indicators from Repro Med's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Repro Med Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At present, Repro Med's Enterprise Value is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	13.8M	15.4M	16.7M	17.5M
Total Revenue	23.5M	27.9M	28.5M	29.9M

Gross Profit Total Revenue

Repro Med fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Short Term Debt	Other Current Liab	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets
Total Assets		0.57	0.94	-0.87	-0.47	0.95	0.74	0.4	0.86	-0.4	0.65	0.78	0.65	0.98	0.82	0.55	0.98	0.82	0.79	0.93	0.99	0.63	0.77	0.95	0.7	0.87
Short Long Term Debt Total	0.57		0.76	-0.1	-0.92	0.31	0.95	0.93	0.71	-0.55	0.37	0.59	0.96	0.44	0.93	0.98	0.41	0.46	0.9	0.48	0.44	0.99	0.61	0.31	0.37	0.57
Total Current Liabilities	0.94	0.76		-0.67	-0.61	0.8	0.9	0.57	0.94	-0.49	0.66	0.8	0.8	0.89	0.94	0.71	0.87	0.83	0.88	0.88	0.89	0.8	0.87	0.8	0.72	0.88
Net Debt	-0.87	-0.1	-0.67		0.05	-0.97	-0.31	0.06	-0.6	0.17	-0.56	-0.57	-0.21	-0.91	-0.43	-0.1	-0.95	-0.68	-0.41	-0.82	-0.93	-0.17	-0.51	-0.98	-0.61	-0.69
Retained Earnings	-0.47	-0.92	-0.61	0.05		-0.26	-0.8	-0.89	-0.63	0.64	-0.33	-0.55	-0.91	-0.31	-0.81	-0.97	-0.33	-0.37	-0.84	-0.42	-0.35	-0.91	-0.36	-0.25	-0.28	-0.44
Cash	0.95	0.31	0.8	-0.97	-0.26		0.51	0.15	0.72	-0.28	0.6	0.68	0.41	0.97	0.61	0.31	0.99	0.75	0.59	0.89	0.99	0.38	0.62	1.0	0.65	0.78
Non Current Assets Total	0.74	0.95	0.9	-0.31	-0.8	0.51		0.84	0.82	-0.47	0.48	0.67	0.95	0.64	0.99	0.9	0.6	0.61	0.94	0.65	0.63	0.95	0.8	0.5	0.51	0.75
Non Currrent Assets Other	0.4	0.93	0.57	0.06	-0.89	0.15	0.84		0.51	-0.45	0.21	0.43	0.9	0.26	0.8	0.91	0.23	0.22	0.79	0.3	0.26	0.91	0.44	0.15	0.18	0.42
Net Receivables	0.86	0.71	0.94	-0.6	-0.63	0.72	0.82	0.51		-0.64	0.71	0.78	0.75	0.78	0.87	0.7	0.79	0.84	0.82	0.86	0.81	0.76	0.76	0.72	0.77	0.83
Good Will	-0.4	-0.55	-0.49	0.17	0.64	-0.28	-0.47	-0.45	-0.64		-0.62	-0.43	-0.5	-0.3	-0.54	-0.64	-0.34	-0.49	-0.43	-0.34	-0.36	-0.64	-0.21	-0.28	-0.65	-0.26
Common Stock Total Equity	0.65	0.37	0.66	-0.56	-0.33	0.6	0.48	0.21	0.71	-0.62		0.48	0.38	0.63	0.55	0.38	0.64	0.65	0.41	0.6	0.65	0.47	0.63	0.6	0.97	0.55
Short Term Investments	0.78	0.59	0.8	-0.57	-0.55	0.68	0.67	0.43	0.78	-0.43	0.48		0.65	0.74	0.75	0.62	0.74	0.88	0.73	0.75	0.74	0.63	0.53	0.67	0.51	0.62
Non Current Liabilities Total	0.65	0.96	0.8	-0.21	-0.91	0.41	0.95	0.9	0.75	-0.5	0.38	0.65		0.52	0.94	0.93	0.5	0.48	0.95	0.63	0.53	0.94	0.65	0.41	0.39	0.71
Inventory	0.98	0.44	0.89	-0.91	-0.31	0.97	0.64	0.26	0.78	-0.3	0.63	0.74	0.52		0.73	0.4	0.98	0.8	0.66	0.9	0.99	0.5	0.75	0.97	0.69	0.83
Total Liab	0.82	0.93	0.94	-0.43	-0.81	0.61	0.99	0.8	0.87	-0.54	0.55	0.75	0.94	0.73		0.89	0.69	0.69	0.94	0.73	0.72	0.94	0.8	0.61	0.58	0.78
Property Plant And Equipment Gross	0.55	0.98	0.71	-0.1	-0.97	0.31	0.9	0.91	0.7	-0.64	0.38	0.62	0.93	0.4	0.89		0.4	0.49	0.88	0.45	0.42	0.98	0.49	0.31	0.36	0.48
Total Current Assets	0.98	0.41	0.87	-0.95	-0.33	0.99	0.6	0.23	0.79	-0.34	0.64	0.74	0.5	0.98	0.69	0.4		0.8	0.67	0.92	1.0	0.47	0.68	0.99	0.69	0.83
Intangible Assets	0.82	0.46	0.83	-0.68	-0.37	0.75	0.61	0.22	0.84	-0.49	0.65	0.88	0.48	0.8	0.69	0.49	0.8		0.62	0.77	0.81	0.54	0.64	0.75	0.71	0.62
Short Term Debt	0.79	0.9	0.88	-0.41	-0.84	0.59	0.94	0.79	0.82	-0.43	0.41	0.73	0.95	0.66	0.94	0.88	0.67	0.62		0.75	0.69	0.9	0.7	0.59	0.43	0.79
Other Current Liab	0.93	0.48	0.88	-0.82	-0.42	0.89	0.65	0.3	0.86	-0.34	0.6	0.75	0.63	0.9	0.73	0.45	0.92	0.77	0.75		0.93	0.51	0.72	0.89	0.66	0.94
Total Stockholder Equity	0.99	0.44	0.89	-0.93	-0.35	0.99	0.63	0.26	0.81	-0.36	0.65	0.74	0.53	0.99	0.72	0.42	1.0	0.81	0.69	0.93		0.5	0.71	0.98	0.71	0.84
Property Plant And Equipment Net	0.63	0.99	0.8	-0.17	-0.91	0.38	0.95	0.91	0.76	-0.64	0.47	0.63	0.94	0.5	0.94	0.98	0.47	0.54	0.9	0.51	0.5		0.62	0.38	0.47	0.57
Accounts Payable	0.77	0.61	0.87	-0.51	-0.36	0.62	0.8	0.44	0.76	-0.21	0.63	0.53	0.65	0.75	0.8	0.49	0.68	0.64	0.7	0.72	0.71	0.62		0.62	0.68	0.85
Cash And Short Term Investments	0.95	0.31	0.8	-0.98	-0.25	1.0	0.5	0.15	0.72	-0.28	0.6	0.67	0.41	0.97	0.61	0.31	0.99	0.75	0.59	0.89	0.98	0.38	0.62		0.65	0.78
Common Stock Shares Outstanding	0.7	0.37	0.72	-0.61	-0.28	0.65	0.51	0.18	0.77	-0.65	0.97	0.51	0.39	0.69	0.58	0.36	0.69	0.71	0.43	0.66	0.71	0.47	0.68	0.65		0.62
Other Current Assets	0.87	0.57	0.88	-0.69	-0.44	0.78	0.75	0.42	0.83	-0.26	0.55	0.62	0.71	0.83	0.78	0.48	0.83	0.62	0.79	0.94	0.84	0.57	0.85	0.78	0.62

Click cells to compare fundamentals

Repro Med Account Relationship Matchups

Repro Med fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	13.9M	39.9M	41.3M	42.3M	28.5M	29.9M
Total Current Liabilities	2.4M	3.7M	4.8M	7.0M	4.5M	4.7M
Net Debt	(5.5M)	(27.1M)	(24.7M)	(12.5M)	(7.0M)	(6.7M)
Retained Earnings	4.9M	3.7M	(910.1K)	(9.6M)	(23.3M)	(22.1M)
Cash	5.9M	27.3M	25.3M	17.4M	11.5M	12.1M
Non Current Assets Total	2.0M	2.4M	4.0M	12.5M	8.2M	8.6M
Net Receivables	3.2M	2.6M	4.3M	4.5M	4.1M	4.3M
Common Stock Total Equity	422.4K	466.8K	480.4K	488.6K	561.9K	373.2K
Liabilities And Stockholders Equity	13.9M	39.9M	41.3M	42.3M	28.5M	29.9M
Non Current Liabilities Total	239.5K	95.6K	1.9M	4.0M	3.7M	3.8M
Inventory	2.4M	6.8M	6.1M	6.4M	3.5M	3.7M
Total Liab	2.6M	3.8M	4.8M	11.0M	8.1M	8.5M
Property Plant And Equipment Gross	985.6K	1.2M	1.2M	7.7M	10.1M	10.6M
Total Current Assets	11.9M	37.5M	37.3M	29.8M	20.3M	21.3M
Intangible Assets	807.1K	843.6K	808.8K	787.2K	754.4K	792.1K
Other Current Liab	1.7M	2.8M	5.6M	3.7M	2.7M	2.8M
Total Stockholder Equity	11.2M	36.2M	36.5M	31.3M	20.4M	21.4M
Property Plant And Equipment Net	985.6K	1.4M	1.2M	7.7M	7.4M	7.7M
Accounts Payable	572.7K	624.9K	1.2M	2.4M	975.2K	502.6K
Cash And Short Term Investments	5.9M	27.3M	25.3M	17.4M	11.5M	12.1M
Common Stock Shares Outstanding	39.1M	41.9M	44.4M	45.0M	45.6M	37.4M
Other Current Assets	387.4K	807.8K	3.1M	2.9M	1.2M	1.3M
Other Stockholder Equity	5.9M	32.0M	36.9M	40.4M	43.2M	45.3M
Common Stock	422.4K	466.8K	480.4K	488.6K	490.9K	395.6K
Net Tangible Assets	10.4M	35.3M	35.7M	30.5M	35.1M	19.3M
Other Assets	207.8K	381.9K	2.0M	4.1M	4.7M	4.9M
Capital Surpluse	6.3M	35.9M	40.8M	44.3M	50.9M	53.4M
Property Plant Equipment	985.6K	1.4M	1.2M	3.9M	4.5M	4.7M
Net Invested Capital	11.2M	36.2M	37.0M	31.8M	20.7M	26.7M
Capital Stock	422.4K	466.8K	480.4K	488.6K	490.9K	505.7K
Net Working Capital	9.5M	33.9M	32.5M	22.8M	15.8M	22.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:

How To Invest In Repro

Details

Is Repro Stock a good investment?

Details

What is Repro Med's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.66)

Earnings Share

(0.26)

Revenue Per Share

0.674

Quarterly Revenue Growth

0.215

Return On Assets

(0.14)

The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Repro Cash Ratio vs End Period Cash Flow Analysis

Cash Ratio vs End Period Cash Flow

Cash Ratio vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Cash Ratio

End Period Cash Flow

Repro Med fundamental ratios Correlations

Repro Med Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Repro Med fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 1.0	Total Current Assets
Total Stockholder Equity	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Short Long Term Debt Total
Total Current Assets	+ 0.99	Cash
Total Stockholder Equity	+ 0.99	Cash

Cash And Short Term Investments	- 0.98	Net Debt
Property Plant And Equipment Gross	- 0.97	Retained Earnings
Cash	- 0.97	Net Debt
Total Current Assets	- 0.95	Net Debt
Total Stockholder Equity	- 0.93	Net Debt
Retained Earnings	- 0.92	Short Long Term Debt Total